Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes-Reference-Cited by-同舟云学术

Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes

Published:2015-08 Issue:2 Volume:28 Page:170-182
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Herrero Ana,Pinto Adán,Colón-Bolea Paula,Casar Berta,Jones Mary,Agudo-Ibáñez Lorena,Vidal Rebeca,Tenbaum Stephan P.,Nuciforo Paolo,Valdizán Elsa M.,Horvath Zoltan,Orfi Laszlo,Pineda-Lucena Antonio,Bony Emilie,Keri Gyorgy,Rivas Germán,Pazos Angel,Gozalbes Rafael,Palmer Héctor G.,Hurlstone Adam,Crespo Piero

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference36 articles.

1. Ras, an actor on many stages: posttranslational modifications, localization, and site-specified events;Arozarena;Genes Cancer,2011

2. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma;Bollag;Nature,2010

3. The Ras-ERK pathway: understanding site-specific signaling provides hope of new anti-tumor therapies;Calvo;BioEssays,2010

4. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation;Canagarajah;Cell,1997

5. Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes;Casar;Mol. Cell,2008

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERK1/2 mitogen‐activated protein kinase dimerization is essential for the regulation of cell motility;Molecular Oncology;2024-09-12

2. Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death;Nature Communications;2024-08-15

3. MEK inhibitors: a promising targeted therapy for cardiovascular disease;Frontiers in Cardiovascular Medicine;2024-07-01

4. Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer;Science;2024-06-07

5. Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors;Pharmaceuticals;2024-03-01